drugset / Trial / NCT03326180

Study of Peri-Articular Anaesthetic for Replacement of the Knee

NCT03326180

Phase 3 Completed 533 enrolled University of Leeds University of Oxford · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The clinical and cost effectiveness of peri-articular liposomal bupivacaine plus bupivacaine hydrochloride compared with bupivacaine hydrochloride alone for post-operative recovery after knee replacement surgery: A multi-centre, patient-blinded, randomised controlled trial.

Timeline

Start
2018-03-29
Primary completion
2021-02-28
Completion
2021-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 100 mg Other
Subject Bupivacaine Other / unclassified 266 mg Other

Indications